News

Paget’s Disease Treatment Market Size, Share, Growth, Trends, Analysis and Forecast 2019 To 2027

According to the latest report published by Acute Market Report, “Paget’s Disease Treatment Market By Type Of Drug Class (Bisphosphonates, Calcitonin Analogues (Salmon Calcitonin), Analgesics, Calcium & Vitamin D Supplements) – Growth, Future Prospects & Competitive Analysis, 2019 – 2027,” the global Paget’s disease treatment market is expected to grow at a CAGR of 3.4% from 2019 to 2027.

Browse the full report at “Paget’s Disease Treatment Market

Market Insights

Paget’s disease is a rare condition in which the normal cycle of bone renewal and repair is disordered or abnormal. This abnormal bone is fragile, has multiple blood vessels, and is larger in size than normal bone. However, in most cases do not cause symptoms, some patients may experience bone pain, fractures, deformities, and in rare cases malignant transformation into tumor. Paget’s disease is most prevalent in geriatric patients due to which countries with highest geriatric population have highest prevalence rates such as U.K, Spain, Italy, France, U.S., Australia, and New Zealand. Paget’s disease when occurs around a joint, treatment is usually delivered specifically to prevent progress of osteoarthritis. In addition, young patients with Paget disease and those with high levels of bone-specific alkaline phosphatase (BSAP) are frequently treated to prevent future complications. Bone deformities are the second most common manifestation with a prevalence ranging from 12% to 36%. The femur and tibia are the most common bones getting affected, bones especially gets bended, which is usually anterolateral in the femur and anterior in the tibia.

Drug classes involved in the Paget’s disease treatment comprises bisphosphonates, calcitonin analogues, analgesics, & supplements (calcium & vitamin D). In 2018, bisphosphonates is expected to dominate the market throughout the forecast period due to key factors such as being first line treatment against Paget’s disease, and it successfully slowdowns the bone remodeling process. The market experts believed that bisphosphonate treatment should be preferred with the intention of normalizing bone regeneration in an expectation that this will restrain disease progression and avoid the development of complications.

North America is identified as the largest Paget’s disease treatment market due to increasing prevalence of Paget’s disease coupled with rising geriatric population, and high awareness related to rare orthopedic diseases & treatment. According to the National Organization for Rare Disorders (NORD), the prevalence of Paget’s disease in the United States is estimated to be 1-2 percent of the general population. However, Europe is expected to dominate the Paget’s disease treatment market during the forecast period from 2019 to 2027 due to rising awareness and prevalence related to Paget’s disease.

Market Competition Assessment:

The Paget’s disease treatment market is growing gradually and awareness related to the disease is growing significantly. However, the pipeline is dry and key companies operating in this market lacked in innovation and ground-breaking treatment. The companies present in the global Paget’s disease treatment market are Novartis AG, Mylan NV, Teva Pharmaceutical Industries Ltd., Neopharma, Inc., Sanofi S.A., Allergan, Fresenius Kabi, Sun Pharmaceutical Industries, Ltd., and Mallinckrodt Pharmaceuticals among others.

Key Market Movements:

  • Increasing prevalence and awareness related to Paget’s disease treatment & diagnosis expected to assist the market growth
  • Incessant demand for development of target-specific treatment for Paget’s disease treatment
  • Being an orphan disease and complexities related to diagnosis and disease management initiative related to research & development activities is not present

Type of Drug Class (2017–2027; US$ Mn)

  • Bisphosphonates
    • Zoledronic acid
    • Pamidronate Disodium
    • Etidronate
    • Tiludronate
    • Alendronate
    • Risedronate
  • Calcitonin Analogues (Salmon Calcitonin)
  • Analgesics
  • Calcium & Vitamin D Supplements

By Geography Segment (2017-2027; US$ Bn)

  • North America
  • Europe
  • Asia Pacific (APAC)
  • Middle East & Africa (MEA)
  • Latin America

About Us
Acute Market Reports is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives.

Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
(US/CANADA) Ph.: +1-855-455-8662
E-mailsales@acutemarketreports.com

pythonskynet

Recent Posts

Best AI side hustles 2025

Understanding the Best AI Side Hustles 2025 The year 2025 is shaping up to be…

2 weeks ago

Alternative Fuel Vehicles Market

Rising Momentum in the Global Alternative Fuel Vehicles Market The global market for Alternative Fuel…

3 weeks ago

Automotive Chiplet Market

Revolutionizing Next-Gen Mobility: New Automotive Chiplet Technology Sets a Breakthrough Standard for Vehicle Performance and…

3 weeks ago

Antiques and Collectibles: The Timeless Appeal of History, Art, and Value

Introduction to Antiques and Collectibles There’s a special kind of magic that comes with antiques…

1 month ago

Freighter Aircraft in 2025: The Power, Innovation, and Future of Air Cargo

What Are Freighter Aircraft? Freighter aircraft—often called cargo planes—are highly specialized airplanes designed or converted…

2 months ago

Smart Road: The Future of Intelligent Transportation Systems

A Smart Road represents the next generation of transportation infrastructure — a remarkable blend of…

2 months ago